Joseph Walter Vazzano - Net Worth and Insider Trading
Joseph Walter Vazzano Net Worth
The estimated net worth of Joseph Walter Vazzano is at least $1 Million dollars as of 2024-11-05. Joseph Walter Vazzano is the CFO of Abeona Therapeutics Inc and owns about 233,868 shares of Abeona Therapeutics Inc (ABEO) stock worth over $1 Million. Joseph Walter Vazzano is also the CFO of Avenue Therapeutics Inc and owns about 58 shares of Avenue Therapeutics Inc (ATXI) stock worth over $131. Details can be seen in Joseph Walter Vazzano's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Joseph Walter Vazzano has not made any transactions after 2024-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Joseph Walter Vazzano
Joseph Walter Vazzano Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joseph Walter Vazzano owns 3 companies in total, including Avenue Therapeutics Inc (ATXI) , Abeona Therapeutics Inc (ABEO) , and Allarity Therapeutics Inc (ALLR) .
Click here to see the complete history of Joseph Walter Vazzano’s form 4 insider trades.
Insider Ownership Summary of Joseph Walter Vazzano
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2021-09-15 | Chief Financial Officer |
| ABEO | Abeona Therapeutics Inc | 2024-04-25 | Chief Financial Officer |
| ALLR | Allarity Therapeutics Inc | 2023-08-01 | director |
Joseph Walter Vazzano Latest Holdings Summary
Joseph Walter Vazzano currently owns a total of 2 stocks. Among these stocks, Joseph Walter Vazzano owns 233,868 shares of Abeona Therapeutics Inc (ABEO) as of April 25, 2024, with a value of $1 Million and a weighting of 99.99%. Joseph Walter Vazzano also owns 58 shares of Avenue Therapeutics Inc (ATXI) as of September 15, 2021, with a value of $131 and a weighting of 0.01%.
Latest Holdings of Joseph Walter Vazzano
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABEO | Abeona Therapeutics Inc | 2024-04-25 | 233,868 | 6.19 | 1,447,643 |
| ATXI | Avenue Therapeutics Inc | 2021-09-15 | 58 | 2.25 | 131 |
Holding Weightings of Joseph Walter Vazzano
Joseph Walter Vazzano Form 4 Trading Tracker
According to the SEC Form 4 filings, Joseph Walter Vazzano has made a total of 3 transactions in Abeona Therapeutics Inc (ABEO) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Abeona Therapeutics Inc is the acquisition of 5,608 shares on April 25, 2024, which cost Joseph Walter Vazzano around $17,609.
According to the SEC Form 4 filings, Joseph Walter Vazzano has made a total of 4 transactions in Avenue Therapeutics Inc (ATXI) over the past 5 years, including 2 buys and 2 sells. The most-recent trade in Avenue Therapeutics Inc is the sale of 6 shares on September 15, 2021, which brought Joseph Walter Vazzano around $11,599.
Insider Trading History of Joseph Walter Vazzano
- 1
Joseph Walter Vazzano Trading Performance
GuruFocus tracks the stock performance after each of Joseph Walter Vazzano's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Walter Vazzano is 19.12%. GuruFocus also compares Joseph Walter Vazzano's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Walter Vazzano within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joseph Walter Vazzano's insider trading performs compared to the benchmark.
Performance of Joseph Walter Vazzano
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.69 | | | | | |
| Relative Return to S&P 500(%) | 4.42 | | | | | |
Joseph Walter Vazzano Ownership Network
Ownership Network List of Joseph Walter Vazzano
Ownership Network Relation of Joseph Walter Vazzano
Joseph Walter Vazzano Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
Joseph Walter Vazzano is the Chief Financial Officer of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, Joseph Walter Vazzano made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .
In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,728 shares were bought by its insiders, resulting in a net purchase of 2,501 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
Joseph Walter Vazzano Mailing Address
Above is the net worth, insider trading, and ownership report for Joseph Walter Vazzano. You might contact Joseph Walter Vazzano via mailing address: 1330 Avenue Of The Americas, 33rd Floor, New York Ny 10019.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
